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National Wildlife Research Center, 4101 LaPorte Avenue, Fort Collins, CO 80521, USA
KATHLEEN A. FAGERSTONE, United States Department of Agriculture/Animal and Plant Health Inspection Service/Wildlife Services,
National Wildlife Research Center, 4101 LaPorte Avenue, Fort Collins, CO 80521, USA
ABSTRACT We evaluated the health effects of GonaConTM Immunocontraceptive Vaccine in individual
white-tailed deer (Odocoileus virginianus) on a fully fenced corporate office campus in suburban New Jersey,
USA. We captured and vaccinated adult females, fawns of both sexes, and yearling and adult males, and
evaluated their health status through field and necropsy observations, assessment of blood chemistry, and
histopathological examination of selected tissues. One 1.0-mL intramuscular injection of vaccine was
delivered by hand to the hind limb of each GonaCon-treated deer. Control deer received sham injections
(ad F) or no injections (yearling and ad M). Mean body-condition scores of GonaCon-treated adult females
and males were greater than those of corresponding control groups. No evidence of limping or impaired
mobility was noted in study deer during the 2-year study. No adverse effects of vaccination were detected in
major organs, organ systems, body condition, fat deposits, or blood chemistry. Injection-site lesions
(granulomatous nodules and sterile abscesses) occurred in the deep hind-limb musculature of >85% of
GonaCon-treated and sham-injected deer but were not detectable externally. Reactions at injection sites and
in lymph nodes were typical responses to injection of vaccines formulated as water-in-oil emulsions,
especially those, like GonaCon, that contain mycobacteria. The formation of injection-site lesions may
be a necessary component of the immune response that causes infertility in treated animals. Natural resource
managers who use GonaCon to manage deer in settings such as developed areas and public parks will
ultimately determine its value and applicability.  2011 The Wildlife Society.
KEY WORDS contraception, gonadotropin releasing hormone, granuloma, infertility, Odocoileus virginianus,
overabundance.
Management of overabundant populations of white-tailed
deer (Odocoileus virginianus) has become a major challenge
for natural resource managers in many urban, suburban, and
public park settings in the United States. Traditional man-
agement methods cannot be used in many such settings
because of safety issues, conflicting views regarding the social
acceptability of hunting, or laws prohibiting the discharge of
firearms (DeNicola et al. 1997). Fertility control may offer a
nonlethal management alternative, especially for deer sub-
populations that are isolated by fencing or natural barriers.
Immunocontraception and other nonlethal methods are
increasingly advocated by the public (Stout et al. 1997,
Lauber et al. 2007) and hold promise as a means of reducing
reproduction in overabundant wildlife populations (Hobbs
et al. 2000, Curtis et al. 2002, Fagerstone et al. 2010).
GonaConTM Immunocontraceptive Vaccine (National
Wildlife Research Center, Fort Collins, CO) is a gonadotropin
releasing hormone- (GnRH-) based water-in-oil emulsion that
has safely induced temporary infertility in many mammalian
species, including free-ranging California ground squirrels
(Spermophilus beecheyi; Nash et al. 2004), captive Norway rats
(Rattus norvegicus; Miller et al. 1997), domestic cats (Felis catus;
Levy et al. 2004), domestic and feral swine (Sus scrofa; Miller et
al. 2003; Killian et al. 2006c), wild horses (Equus caballus; Killian
et al. 2006a), bison (Bison bison;Miller et al. 2004a), elk (Cervus
elaphus; Killian et al. 2009), and white-tailed deer (Miller et al.
2008b; Gionfriddo et al. 2009). It can be administered as one
intramuscular injection that suppresses reproduction in treated
animals of both sexes for multiple years (Miller et al. 2004b).
GonaCon was registered by the United States Environmental
Protection Agency in September 2009 as a restricted-use
product for the contraception of adult, female, white-tailed
deer via hand injection (Fagerstone et al. 2010).
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We assessed the health effects of GonaCon treatment in
white-tailed deer adults and fawns of both sexes. Adult
females were the primary focus of the study because they
will be the targets of operational applications of GonaCon
vaccine by natural resource managers. Fawns were tested
because a GnRH immunocontraceptive agent could poten-
tially be delivered orally in the future, and treated bait might
be consumed by deer of all ages. We also tested GonaCon in
yearling and adult males. Although GonaCon is not regis-
tered or recommended for use in male deer (Killian et al.
2005, Curtis et al. 2008), antlerless males could inadvertently
be treated during winter management activities because they
can be mistaken for females. Inadvertent treatment of males
could also occur if a new GnRH vaccine is registered for
remote injection or oral delivery in bait.
This research was part of a larger investigation that also
evaluated GonaCon’s contraceptive efficacy, which is
addressed separately in another manuscript (Gionfriddo
et al. 2011). The objective of the research covered in this
manuscript was to evaluate the health effects of GonaCon
Immunocontraceptive Vaccine in wild white-tailed deer
through field observations, necropsy examinations, labora-
tory assessment of blood chemistry, and histopathological
analysis of selected reproductive and other tissues. We
tested several hypotheses to determine whether mean
body condition scores were higher in some groups of
study deer than in others. In addition, we tested a series
of hypotheses to determine whether mean values for blood-
chemistry parameters differed between treatment groups
(GonaCon-injected ad F vs. sham-injected control F) and
between years (pretreatment vs. posttreatment). We also
tested the hypotheses that the incidence of injection-
site lesions was higher 1) in GonaCon-treated than in
sham-injected control adult female deer, and 2) in
GonaCon-treated adult female deer that became pregnant
than in those that did not, for each year. Finally, we tested
the hypothesis that the GonaCon-injected rear leg of each
deer was greater in circumference near the injection-site
location than the other rear leg.
STUDY AREA
The study was conducted on a fully fenced (2.4-m-tall chain-
link), 123-ha corporate office campus near Madison in New
Jersey, USA. Habitat types included hardwood forest (about
20%), old fields reverted to grasslands and savannah (about
20%), lawns (about 40%), and landscaped areas around
buildings. Deer were easily observed from paved and gravel
roads located throughout the study area. During the 2-year
study, a few deer emigrated or immigrated by running
through security gates opened briefly by guards to allow
ingress and egress of motor vehicles.
Northern New Jersey experienced a continental type of
climate, with cold, damp winters and hot, humid summers.
At Morris Plains, about 8.5 km northwest of the study area,
mean monthly temperatures (1945–1990) ranged from
2.48 C (January) to 22.48 C (July). Mean annual precipi-
tation (1941–1990) was 128.8 cm, with an annual growing
season of about 142 days (Office of the New Jersey State
Climatologist 2011; U.S. Department of Agriculture Natural
Resources Conservation Service, National Water and
Climate Center 2011).
METHODS
Capture and Treatments
All study deer.—We captured deer at night with tranquil-
izer darts fired from a Pneu-Dart rifle (Model 171; Pneu-
Dart, Inc., Williamsport, PA). We used a mixture of
Telazol1 (4.5 mg/kg; Fort Dodge Animal Health, Fort
Dodge, IA) and xylazine hydrochloride (2.5 mg/kg; Bayer,
Leverkusen, North Rhine-Westphalia, Germany) to
immobilize deer. One of us (AJD) estimated deer body
masses in the field by handling deer and by palpating body
contours strongly influenced by fat deposits (Riney 1960,
Robinson 1960, Audige´ et al. 1998). We fitted deer with
numbered ear tags and radiotelemetry collars equipped with
mortality sensors (Model M2520; Advanced Telemetry
Systems, Isanti, MN). We delivered a 1.0-mL injection
(GonaCon vaccine or a sham material; see below) by hand
to the deep musculature of the upper hind limb of each deer.
If a deer had been darted in a hind limb we hand-injected the
opposite hind limb. We administered tolazoline hydrochlo-
ride (3.0 mg/kg; Lloyd, Inc., Shenandoah, IA) intravenously
to reverse anesthesia and hasten recovery of deer before we
released them at their capture sites.
Adult females.—During July and early August 2005, we
captured all adult females present on the study area (n ¼ 47)
and collected a blood sample from the jugular or femoral vein
of each animal to measure pretreatment blood-chemistry
parameters. We injected each female with GonaCon
Immunocontraceptive Vaccine (n ¼ 32; each 1.0-mL dose
of vaccine contained 1,000 mg of conjugated GnRH–
mollusk protein) or with a sham material (n ¼ 15). The
sham material consisted of AdjuVacTM adjuvant (National
Wildlife Research Center, Fort Collins, CO) and mollusk
stabilizing buffer (i.e., GonaCon vaccine without GnRH and
without the mollusk protein that usually serves as the carrier
molecule to which GnRH is conjugated).
Fawns andmales.—We captured and vaccinated 8-month-
old female fawns (n ¼ 4) in February 2006 to determine the
health effects of vaccination with GonaCon vaccine on
young deer treated during their first winter. To evaluate
the health effects of treating young fawns with GonaCon,
we captured and vaccinated 3- to 4-month-old fawns
(n ¼ 16) during September–October 2006. We captured
and vaccinated yearling and adult males (n ¼ 10) during
March 2007 to assess the health effects of wintertime treat-
ment of male deer with GonaCon. To provide baseline data
on untreated (control) males, we killed (via gunshot to head
or neck) and necropsied previously uncaptured males (year-
lings and ad; n ¼ 13) during October 2007.
Evaluation of Health Effects of Vaccination
on Treated Deer
We used field observations, necropsy examinations, labora-
tory assessment of blood chemistry, and histopathological
evaluation of selected reproductive and other tissues to
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identify potential health and safety problems associated with
GonaCon treatment. We observed all study animals during
spring(s) and summer(s) between their capture and October
2007. During field observations we looked for evidence of
limping, impaired mobility, reduced range of motion of
limbs, other abnormal behavior, and externally visible injec-
tion-site reactions. In October 2007, at the conclusion of
field activities, we collected 62 deer (including representa-
tives of all of the above treatment and control groups) after
shooting them in the head or neck with a high-powered rifle.
We shot deer as they foraged or rested, without a chase. We
collected blood from each deer via cardiac puncture within
1 min of the animal’s death, and we stored blood samples in a
cooler or refrigerator before we isolated the serum via
centrifugation and shipped it to a laboratory for analysis
of blood chemistry. For the original group of adult females
(the only experimental deer from which we collected blood at
the time of initial capture), we used analysis of variance
(ANOVA; mixed model) to compare mean values of
blood-chemistry parameters of vaccinated versus control
deer. Treatment group and year were treated as fixed effects
and individual deer were treated as a random effect in the
mixed-model analysis.
An experienced wildlife veterinarian performed standard
necropsy examinations (Munson 2010) in the field immedi-
ately after deer were killed and blood samples were collected.
We fixed and preserved tissue samples in formalin before we
shipped them to Colorado, USA, for histopathological
evaluation (Colorado Histo-Prep, Fort Collins, CO).
Samples collected included ovaries, fallopian tubes, uteri,
hypothalami-anterior pituitary glands, mammary glands,
and the injection-site tissues and their draining (popliteal
and iliac) lymph nodes. We also submitted other apparently
abnormal tissues, if present, for histopathological analysis.
We used Fisher’s exact tests to determine whether the inci-
dence of injection-site lesions was greater 1) in GonaCon-
treated than in sham-injected control adult female deer,
and 2) in pregnant than in nonpregnant GonaCon-treated
adult female deer for each year.
Fat stores and general body condition were evaluated for
each deer at necropsy to provide information on individual
and general herd health, which may have influenced vaccine
efficacy. We measured (to the nearest 0.5 mm) the thickness
of the thickest fat layer at the base of the heart and on the
ventral surfaces of the kidneys; of the 6 indicator sites used by
Kistner et al. (1980), these are the most predictive of body
composition (Cook et al. 2001). Based on thickness, we
assigned a value of 1–5 to each heart or kidney fat deposit
(0.0–2.0 mm ¼ 1, 2.5–4.5 mm ¼ 2, 5.0–7.0 mm ¼ 3, 7.5–
9.5 mm ¼ 4, 10.0 mm ¼ 5). For each deer, we catego-
rized general fat deposits as ‘‘little,’’ ‘‘little to moderate,’’
‘‘moderate,’’ ‘‘moderate to abundant,’’ or ‘‘abundant,’’ and
we assigned values of 1–5 for these categories (‘‘little’’ ¼ 1,
‘‘abundant’’ ¼ 5). In addition, the necropsy veterinarian
classified each animal’s general body condition on a scale
of 1 through 4, based upon body size (relative to age),
muscularity, and externally perceptible fat stores (1 ¼ poor
poor condition, with ribs, spine, and all bony prominences
starkly visible, and with no fat cover in the concave rump;
2 ¼ thin condition, with the spine, ribs and bony promi-
nences clearly but not starkly visible, with nomuscle develop-
ment, and with little palpable fat in the flat rump; 3 ¼ fair
condition, with the spine visible, the ribs and bony prom-
inences palpable but only slightly visible, and with little
muscle development; 4 ¼ good condition, with spine, ribs,
and prominences not visible, and with at least moderate
muscularity, but not a ‘‘fat’’ animal). None of the deer on
this study site was considered ‘‘fat’’ or in ‘‘excellent’’ body
condition. For each deer, the 4 values for fat stores and body
condition were summed to produce a body condition score
that took into account body size, musculature, and both
externally apparent and deep internal fat stores. If one of
the values was missing, we replaced it with the mean of the
other 3 values, rounded to the nearest integer. We used these
body condition scores, which ranged from 4 to 16, to assign
each deer to a body condition class (4–5 ¼ ‘‘poor,’’ 6–
8 ¼ ‘‘thin,’’ 9–11 ¼ ‘‘fair,’’ 12–16 ¼ ‘‘good’’). Body con-
dition scores usually vary among males, females, and fawns
due to differences in their ability to store fat and in their need
to metabolize fat stores as the autumn breeding season
proceeds (Kistner et al. 1980). Accordingly, we calculated
a mean body-condition score for each of the following
groups: GonaCon-treated adult females, control adult
females, GonaCon-treated adult males, control adult males,
male fawns vaccinated at 3–4 months of age, female fawns
vaccinated at 3–4 months of age, and female fawns vacci-
nated at 8 months of age (Table 1). Modified Kistner scores
have been used successfully to evaluate body condition in
many cervids (e.g., Cook et al. 2001, 2007; Stephenson et al.
2002; Peterson and Messmer 2007). Although our body
condition scores may not provide an absolute measure of
fat deposits or body condition, they do provide standardized
relative measures of these variables that permit valid com-
parisons of treatment–demographic groups within our study.
To determine whether injections had caused a swelling of
hind limbs, or whether limb disuse had caused muscular
atrophy, we used a standard vinyl tape measure to determine
the circumference of each thigh of each deer at necropsy. We
held the end of the tape at the top edge of the patella at the
insertion of the quadriceps muscle group and wrapped the
tape around the thigh at the narrowest point caudal to the
stifle. Although this point was very slightly distal to the
injection site, it provided a practical, standardized location
for comparative measurements that would detect differences
in girth at the injection sites. We used a paired t-test to
compare the left and right thigh circumferences of each deer.
For all statistical analyses, we used a ¼ 0.05. The
Institutional Animal Care and Use Committee of the
National Wildlife Research Center approved all aspects of
this research.
RESULTS
All Study Deer
With one exception, no overt signs of limping, restricted
range of motion of limbs, or impaired mobility were observed
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in any vaccinated or control deer in this study. No externally
visible evidence of injection-site reactions was observed in
live deer in the field or in dead deer prior to dissection of the
musculature at injection sites during necropsies. Hind limb
circumferences measured at the injection sites did not differ
(P > 0.05) in any animal in this study.
Major organs and organ systems were normal in most study
deer, although several abnormalities (apparently unrelated to
capture, handling, and treatment) were noted at necropsy.
Livers of 5 (4 GonaCon-treated and 1 control) deer and
spleens of 2 (1 GonaCon-treated and 1 control) deer showed
evidence of current or previous parasitic infection. Several
small nodules were found in the lungs of 2 (1 GonaCon-
treated and 1 control) deer and in the parenchyma of the
pancreas of 1 (control) deer.
Field estimates of deer body weights at initial capture
ranged from 32 kg to 57 kg. Skin was normal on all
examined deer, with either no external parasites or a few
ticks present. Ovaries and uteri in many GonaCon-treated
females (ad and fawns) were small and inactive. Ovarian and
uterine quiescence is a normal response to GonaCon because
the vaccine disrupts the synthesis of reproductive hormones.
Dissection of the deep musculature (semimembranosus,
semitendinosus, and biceps femoris muscles) at injection
sites revealed lesions of 2 types within muscles and in fascia
between muscles: hard nodules and abscesses. Nodules were
partially or fully encapsulated, yellowish-white globular
masses that occurred singly or in groups; most were 3–
6 mm in diameter. Histopathologic examination confirmed
that these nodules were chronic inflammatory granulomas of
long duration, characterized by macrophages, multinucleated
giant cells, vacuoles, and mineralized and/or necrotic centers.
Most abscesses were small (0.5–4 cm3; n ¼ 6) or moderate
(30–100 cm3; n ¼ 5) in size, but one was very large (about
1,000 cm3). During histopathological examinations,
abscesses were identified as granulomas that had progressed
to sterile abscesses.
Adult Females
Of the 30 adult female deer (18 GonaCon-treated and 12
control) that were collected in October 2007, 26 were
assigned body condition scores based on necropsy evaluation
(Table 1). None of the 10 control females and only 3 of the
16 GonaCon-treated females were in ‘‘good’’ condition. The
mean body condition score for all GonaCon-treated adult
females (regardless of pregnancy outcomes) was higher than
that of controls (t24 ¼ 1.92, P ¼ 0.034; Table 1). The mean
body condition score for GonaCon-treated adult females
that became pregnant during the study (1 or both yr) did
not differ from that of control females (t16 ¼ 0.47,
P ¼ 0.323).
Fat reserves in necropsied study deer generally were mea-
ger. Ten of 16 GonaCon-treated and 6 of 8 control females
had ‘‘little’’ general body fat and 3 others (1 GonaCon-
treated and 2 control) had ‘‘little-to-moderate’’ fat. Only 3
deer (all GonaCon-treated) had ‘‘moderate’’ or ‘‘moderate-
to-abundant’’ fat, and none had ‘‘abundant’’ fat. Fat reserves
on the heart and kidneys ranged from 0 mm to 10 mm in
thickness; most deer had 2–4 mm of fat.
None of the 15 blood-chemistry parameters we measured
differed (P > 0.05) between GonaCon-treated and control
adult female deer at the time of initial capture in July–August
2005 or when deer were collected in October 2007 (Table 2).
Although 2005 and 2007 mean values of some blood-chem-
istry parameters differed, all values were within the normal
ranges for adult white-tailed deer (Seal et al. 1981, Kie et al.
1983) except creatinine phosphokinase (CPK), potassium,
and phosphorus values for 2007, which were abnormally
high.
Injection-site lesions (hard nodules, or hard nodules and
abscesses) were found at necropsy in 17 (94%) of 18 adult
female deer that had been vaccinated with GonaCon, and in
9 (82%) of 11 adult female deer that had received sham
injections (Table 3). The incidence of lesions was not higher
in GonaCon-treated females (P ¼ 0.316) than in controls.
Of the 17 GonaCon-treated females with hard nodules at
injection sites, 8 (47%) also had abscesses (2 small, 5 mod-
erate, 1 large). Two (22%) of the 9 sham-injected control
females with hard nodules also had abscesses (both small).
Among GonaCon-treated adult females, the incidence of
lesions was not higher in pregnant (n2006 ¼ 6; n2007 ¼ 8)
than in nonpregnant (n2006 ¼ 12; n2007 ¼ 13) animals for
either year (P2006 ¼ 0.333; P2007 ¼ 0.619). Injection-site
tissue samples from 12 adult females (7 GonaCon-treated
Table 1. Body condition scores of GonaCon-treated and control white-tailed deer in New Jersey, USA, 2005–2007.
Treatment group
Body condition
N Group mean SEMPoor Thin Fair Good
Ad F: GonaCon 2 7 4 3 16 8.8 0.8
Ad F: controla 3 5 2 0 10 6.8 0.6
3- to 4-month-old F fawns: GonaCon 1 1 2 1 5 8.8 1.4
3- to 4-month-old M fawns: GonaCon 1 3 2 0 6 7.7 1.1
8-month-old F fawns: GonaCon 0 1 1 0 2 8.0 1.0
Ad M: GonaCon 0 0 1 3 4 12.0 1.2
Ad M: controlb 0 3 2 0 5 8.4 0.9
Totals 7 20 14 7 48
 Body condition scores were based on evaluation of body size (relative to age), musculature, and both externally apparent and deep internal fat stores.
a Each control ad F received a sham injection of AdjuVac adjuvant and mollusk stabilizing buffer (i.e., GonaCon vaccine without the GnRH and mollusk
hemocyanin).
b Control ad M received no injections.
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and 5 control) were submitted for histopathological exam-
ination. Chronic granulomatous inflammation was detected
in 11 of these 12 samples, and the remaining sample had a
chronic abscess. Necrosis of muscle fibers at injection sites
was common.
Injection sites of tranquilizer darts used at initial capture
(summer 2005) were found in 7 (24%) of 29 adult female deer
(GonaCon-treated and controls) at necropsy in October
2007. A tissue sample from the tranquilizer-dart injection
site of an adult female was examined histopathologically and
found to have chronic granulomatous inflammation.
At necropsy, the popliteal lymph node in the hind leg that
was hand-injected was enlarged or hard in 11 (61%) of 18
GonaCon-treated adult female deer and in 6 (50%) of 12
sham-injected control females. The iliac lymph node associ-
ated with the injected hind leg was enlarged or hard in 6
(35%) of 17 GonaCon-treated females and in 6 (50%) of 12
sham-injected females.
Twenty-five popliteal or iliac lymph nodes from 14 (10
GonaCon-treated and 4 control) adult study females were
submitted for histopathological examination. Chronic gran-
ulomatous inflammation was found in 4 unidentified (pop-
liteal or iliac) lymph nodes from 3 (2 GonaCon-treated and 1
control) deer. Chronic hyperplasia was detected in 2 popliteal
lymph nodes (from 2 GonaCon-treated deer) and 1 uniden-
tified lymph node (from a control deer). Acute hemorrhage
was noted in 2 unidentified lymph nodes (from 1 GonaCon-
treated and 1 control deer). Foreign material was found in
one unidentified lymph node (from a GonaCon-treated
deer). No significant findings were reported for 5 popliteal,
4 iliac, and 7 unidentified lymph nodes.
In several lymph nodes in our study deer (both sexes),
vacuoles were found among the macrophages and multi-
nucleated giant cells or within their cytoplasm. These
vacuoles were probably mineral oil droplets from the
AdjuVac in GonaCon.
Table 2. Means and standard errors of the means for blood chemical parameters of adult, female, white-tailed deer in GonaCon-treated groups and control
groups in New Jersey, USA, 2005–2007. Values marked with different letters (A and B) within a row differed significantly from each other. Note that some
values are marked with both A and B. Values for 2005 are pretreatment values. ALK, alkaline phosphatase; CPK, creatinine phosphokinase; ALT, alanine
aminotransferase; BUN, blood urea nitrogen.
Parameter
2005 2007
Group, Pb Yr, Pc
Controla GonaCon Control GonaCon
Mean SE Mean SE Mean SE Mean SE
Sodium (mEq/L)d 142.5 A 3.1 142.0 A 2.2 148.6 A,B 3.5 157.5 B 2.9 0.174 <0.001
Potassium (mEq/L)e 4.8 A 0.6 4.9 A 0.4 11.5 B 0.7 10.7 B 0.6 0.562 <0.001
Calcium (mg/dL) 8.7 A 0.3 8.6 A 0.2 9.7 B 0.3 10.3 B 0.3 0.399 <0.001
Phosphorus (mg/dL) 5.7 A 0.6 5.3 A 0.4 11.6 A 0.7 11.6 A 0.6 0.796 <0.001
ALK (U/L)e 32.6 A 30.3 26.2 A 20.8 205.5 B 33.9 215.7 B 27.7 0.947 <0.001
Glucose (mg/dL)d 142.8 A 25.2 150.0 A 17.3 189.0 A 28.2 183.5 A 23.0 0.972 0.098
Total protein (g/dL) 6.6 A 0.2 6.7 A 0.15 6.7 A,B 0.3 7.3 B 0.2 0.111 0.052
Albumin (g/dL) 2.7 A 0.1 2.62 A 0.1 2.6 A 0.1 2.8 A 0.1 0.576 0.793
Globulin (g/dL) 3.9 A 0.2 4.0 A 0.1 4.1 A,B 0.2 4.6 B 0.2 0.080 0.012
CPK (U/LD)e 345.7 A 1,667.4 241.2 A 1,141.6 3,388.3 B 1,864.2 6,332.9 B 1,522.1 0.369 0.005
Total bilirubin (mg/dL) 0.1 A 0.0 0.10 A 0.0 0.3 B 0.0 0.4 B 0.0 0.817 <0.001
ALT (U/L)d 26.8 A 5.5 23.5 A 3.8 59.5 B 6.2 45.7 B 5.0 0.104 <0.001
Creatinine (mg/dL) 1.0 A 0.1 1.2 A 0.1 1.4 B 0.1 1.6 B 0.1 0.059 <0.001
BUN (mg/dL) 17.3 A 2.4 18.1 A 1.7 22.0 A 2.7 21.1 A 2.2 0.986 0.094
Amylase (U/L) 106.8 A 10.2 115.9 B 7.0 133.6 A,B 11.3 140.8 B 9.2 0.426 0.006
a Means are from the PROC MIXED procedure in SAS.
b Between-groups comparison.
c Between-yr comparison.
d The inverse (1/x) was used for ANOVA. The P-value reported in the table is the value for the ANOVA of the inverse values.
e The natural log (ln) was used for ANOVA. The P-value reported in the table is the value for the ANOVA of the natural logs.
Table 3. Occurrence of injection-site lesions in wild white-tailed deer injected withGonaCon Immunocontraceptive Vaccine or a shammaterial in New Jersey,
USA, 2005–2007.,
Treatment groupa Deer examined Deer with injection-site lesions Deer without injection-site lesions
Ad F: GonaCon 18 17 (94%) 1 (6%)
Ad F: sham 11 9 (82%) 2 (18%)
3- to 4-month-old fawns: GonaCon 12 8 (67%) 4 (33%)
8-month-old fawns: GonaCon 2 2 (100%) 0 (0%)
Ad M: GonaCon 6 6 (100%) 0 (0%)
Totals 49 42 (86%) 7 (14%)
 Sham material consisted of AdjuVac adjuvant and mollusk stabilizing buffer (i.e., GonaCon vaccine without the GnRH and mollusk hemocyanin).
 No injection-site lesions were found in 13 ad M control deer that received no injections.
a Ages in this column are ages at time of injection.
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Fawns (F, 8 Months Old)
Two of the 4 fawns vaccinated in February 2006 were
collected for necropsy in October 2007. Deer number 76
was ‘‘thin’’ based upon body condition score, with ‘‘little’’
general body fat. Deer number 78 was in ‘‘fair’’ body con-
dition, with ‘‘little-to-moderate’’ general body fat (Table 1).
Heart and kidney fat deposits were 3–5 mm thick in these 2 deer.
Lesions were found at vaccine injection sites in both deer at
necropsy (Table 3). An intramuscular scar caused by a tran-
quilizer dart also was found in the hind leg of deer number
78. The popliteal and iliac lymph nodes were hard in deer
number 78; only the popliteal lymph node was hard in deer
number 76.
Fawns (M and F, 3–4 Months Old)
Twelve of the 16 (8 M and 8 F) fawns we captured and
vaccinated in September–October 2006 were collected and
necropsied in October 2007. Although body condition varied
substantially, half of these deer were in ‘‘poor’’ or ‘‘thin’’
condition, and only one was in ‘‘good’’ condition
(Table 1). General fat deposits were ‘‘little’’ in half of these
deer, and no deer had more than ‘‘moderate’’ fat stores. Heart
and kidney fat stores were2 mm in thickness in 4 of the 12
necropsied deer, and from 3 mm to 10 mm in the remaining
deer (n ¼ 7) that we evaluated.
Vaccine injection-site lesions (hard nodules, no abscesses)
were found in 8 (67%; 5 [100%] of 5 F and 3 [43%] of 7 M;
Table 3), and tranquilizer dart scars were found in 7 (58%)
of the 12 GonaCon-treated deer for which these data
were recorded. Histopathological examination of tissue
samples taken from the vaccine injection sites of 2 deer
detected chronic granulomatous inflammation in both cases.
One of these 2 deer also had chronic granulomatous inflam-
mation in its other hind limb from the tranquilizer dart
injection.
Enlargement of the popliteal lymph node was observed at
necropsy in 3 (27%) of 11 examined deer for which data were
recorded, and enlargement of the iliac lymph node was
detected in 1 of these 3 deer. The popliteal and iliac lymph
nodes from 2 (1 M and 1 F) of these 3 deer were examined
histopathologically. One (unidentified) lymph node from the
male had chronic granulomatous inflammation, and acute
hemorrhage was found in one lymph node from the female.
The remaining lymph node from each animal showed no
signs of pathology.
Adult Males
Of the 10 adult males that were captured and vaccinated with
GonaCon duringMarch 2007, 2 died of unknown causes and
2 left the study site before October 2007. Body condition
scores were determined for 4 of the 6 remaining males; the
mean was higher than that for 5 noninjected control males
(t5 ¼ 2.31, P ¼ 0.032; Table 1). Heart and kidney fat
deposits were 4–8 mm thick in 3 males that had ‘‘moderate’’
general fat deposits, and they were 2–4 mm thick in a male
that had ‘‘little-to-moderate’’ general fat deposits.
Vaccine injection-site lesions were observed in all 6 males at
necropsy (Table 3), but no tranquilizer dart wounds or scars
were found. Two (33%) of these 6 males had small abscesses
in addition to hard nodules. Popliteal lymph node reactions
were evident at necropsy in 5 (83%) of these males.
Enlargement of the iliac lymph node was seen in 2 (33%)
of the males. Relatively small testes and delayed or abnormal
antler development were observed in 2 of the adult males and
in males that had been vaccinated as 3- to 4-month-old
fawns (J. P. Gionfriddo, unpublished work).
Control Males
Thirteen previously untreated males (12 of which had never
been captured) were collected for necropsy during October
2007 for comparison with GonaCon-treated males. Heart
and kidney fat deposits were 5 mm, and general fat depos-
its were ‘‘little’’ to ‘‘moderate’’ in 5 control males we evaluated
at necropsy. Necropsy observations and photographs of the
other 8 control males indicated that they also were generally
in ‘‘thin’’ to ‘‘fair’’ body condition (J. P. Gionfriddo, unpub-
lished work).
DISCUSSION
Treatment with GonaCon Immunocontraceptive Vaccine
caused no serious adverse effects on deer mobility, major
organs and organ systems, or general health and welfare.
Intramuscular injection-site lesions were the only adverse
effect of vaccination that we detected via field observations,
necropsy examinations, laboratory assessment of blood
chemistry, and histopathological evaluation of selected
reproductive and other tissues collected from study deer.
These results are consistent with those of earlier studies of
GonaCon vaccination of white-tailed deer (Killian et al.
2006b, Gionfriddo et al. 2009). In New York, USA,
Curtis et al. (2008) detected no adverse health effects (except
injection-site lesions) associated with hand- and remote-
vaccination of female white-tailed deer with 2 early formu-
lations of GonaCon. Instead of AdjuVac, Freund’s complete
adjuvant (FCA) was used in the primary dose and Freund’s
incomplete adjuvant (FIA) (Freund 1956) was used in the
booster injection.
Although transitory limping can be common among
animals that receive intramuscular vaccinations that produce
injection-site inflammation and granulomas (Macy 1997),
we saw no limping or decreased mobility in injected deer in
this study. Although histopathological evaluation found
chronic granulomas in both rear legs of one of the adult
males (from the tranquilizer dart and a GonaCon hand
injection), the animal was never seen limping during many
field observations in 2007.
Body Condition and Fat Reserves
Prior to the start of our field research, deer had not been
actively managed on the study site for many years, and the
herd had increased to about 95 animals by early spring 2005
(A. J. DeNicola, White Buffalo, Inc., unpublished data). At
capture in July 2005, most deer were noticeably thin, as
reflected in their low body masses. Sustained and severe
overbrowsing by deer was evident in the condition of native
and ornamental vegetation throughout the study site. Thus it
was not surprising that fat reserves of study deer at necropsy
generally were meager.
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GonaCon-treated adult females, especially those that had
not been pregnant during the field study, were in better body
condition at necropsy than control females. By relieving
females of the annual energetic burdens of gestation and
lactation, immunocontraception may have enabled treated
deer to maintain better body condition than control females
that produced and raised fawns (McShea et al. 1997). Body
condition was not evaluated in previous GonaCon studies.
The effects of porcine zona pellucida (PZP) immunocon-
traception on body condition have been equivocal. Adult
female white-tailed deer contracepted with a PZP vaccine
in Connecticut, USA were not in better condition than
untreated controls after a 3-year field study (Walter et al.
2003). Among captive white-tailed deer in Pennsylvania,
USA, no differences in annual autumn body weights were
detected between PZP-treated and control females during a
4-year vaccine trial (Miller et al. 2001). On the other hand,
female deer successfully contracepted with PZP in Virginia,
USA were heavier 1 year posttreatment than untreated con-
trol females that had become pregnant (Kirkpatrick et al.
1997). Many deer treated with PZP undergo repeated
estrous cycling that is energetically costly and may adversely
affect body condition (Miller et al. 2009). In addition, fer-
tilization during later estrous cycles can produce fawns whose
late birthdates could reduce their survivorship during their
first winter (McShea et al. 1997). GonaCon does not cause
repeated estrous cycling.
The better condition of GonaCon-treated males when
compared to control males may be related to the rut and
to the relatively short interval between vaccination and
necropsy. Control males may have lost body condition
through seasonal rut-associated behavior such as fasting,
sparring, and chasing. Although GonaCon-treated males
generally do not grow as large as untreated males (Killian
et al. 2005), males in our study were injected with GonaCon
in March 2007 and killed in October 2007, perhaps
before some effects of the vaccine (such as reduced muscle
development) were manifested.
Blood Chemistry
Blood-chemistry parameters may be influenced by many
factors, including sex, age (Johnson et al. 1968), season,
reproductive status (Klinger et al. 1986), nutrition (Sams
et al. 1998), and capture-related factors such as capture and
handling methods (Mautz et al. 1980, Kock et al. 1987b,
DelGiudice et al. 1990), including the use of immobilizing
agents (Marco and Lavı´n 1999, Poljicˇak-Milas et al. 2006,
Vengusˇt et al. 2006). Several aspects of our blood-sampling
procedures may have affected blood parameters and could
have contributed to differences between treatment groups or
years. At initial capture in 2005, blood was drawn from the
jugular veins of live deer, whereas cardiac puncture of lethally
gunshot deer was used at the end of the field study in 2007.
The latter collection method may have affected the poststudy
(2007) values of some blood parameters (White and Cook
1974). For example, cardiac puncture of a dead animal tends
to yield higher values for CPK, potassium, and phosphorus
than venipuncture of a live animal, and trauma associated
with lethal shooting also can elevate these parameters
(Savignano et al. 1969, Seal et al. 1981, Latimer et al.
2003). Creatinine phosphokinase, potassium, and phos-
phorus were the only blood-chemistry parameters in our
study with values outside the normal ranges for adult
white-tailed deer. A second potential capture-related source
of variation in blood-chemistry results was our use of immo-
bilizing agents in 2005 but not in 2007. These compounds
may affect blood parameters and could have influenced our
results (Seal and Bush 1987). Finally, observed differences in
the values of some blood parameters could be due to seasonal
(July vs. October) variation in nutrition and physiology (Seal
et al. 1981, Waid and Warren 1984).
Despite the above limitations, our data show that
GonaCon caused no serious adverse health effects that were
reflected in blood parameters. Other researchers have
reported similar results. Curtis et al. (2008) measured 28
standard blood parameters in white-tailed deer in New York
and found no differences between GnRH-treated and con-
trol animals. Killian et al. (2006b) used standardized meth-
odology under carefully controlled conditions to handle
captive, GonaCon-treated, white-tailed deer and to sample
their blood. Their comparison of the blood chemistry and
hematology of 19 captive adult females detected no statisti-
cally significant treatment effects for any of the 33 blood
parameters tested. As expected, however, seasonal changes in
some variables were detected via repeated sampling over a
20-week period (Killian et al. 2006b).
Posttreatment values for CPK, potassium, and phosphorus
were abnormally high in our study deer (Table 2). Elevated
CPK values usually reflect stress or trauma to heart, brain, or
skeletal muscle. Lethal gunshot wounds to the head or neck,
and cardiac puncture for blood collection immediately after
death could have caused CPK to increase dramatically. Stress
and tissue damage associated with chronic inflammation at
injection sites and in lymph nodes (reactions to injection)
also could have contributed to the elevation of CPK.
Evaluation of CPK values may not be useful due to the
extreme fluctuations that commonly occur. For example,
200-fold increases in serum CPK were observed in penned
white-tailed deer 24 hr after deer were physically restrained
(Seal et al. 1972).
Elevated concentrations of potassium and phosphorus, like
CPK, often are associated with excess destruction or necrosis
of cells, and may reflect the extent of tissue (especially
muscle) damage (Kock et al. 1987a, Latimer et al. 2003).
Wilber and Robinson (1958) collected Maryland, USA
white-tailed deer via lethal gunshots to neck vertebrae and
then immediately sampled blood via heart puncture. They
found consistently high concentrations of plasma potassium
(similar to our values) and phosphorus, which they attributed
to ‘‘shock.’’ Using similar methods in Oklahoma, USA, Sams
et al. (1998) found very high serum phosphorus concentrations
in white-tailed deer. Elevated potassium and phosphorus con-
centrations in our study deer were likely due to muscle necrosis
associated with collection of deer and blood samples.
Mean posttreatment alkaline phosphatase (ALK) values
showed a 6-fold increase from pretreatment values in our
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study, but they remained within the ranges of values reported
for white-tailed deer (e.g., Sams et al. 1998, Curtis et al.
2008) and for our sample of noninjected control male deer
(x ¼ 221:3, SE ¼ 48.5, n ¼ 13). A published range of
normal values for white-tailed deer could not be found for
this variable, but the range is very broad for large mammals
and, therefore, ALK is not a sensitive indicator (Latimer
et al. 2003).
Injection-Site Lesions
The occurrence of intramuscular injection-site lesions in 5
(29%) of 17 GonaCon-treated deer in a previous field study
(Gionfriddo et al. 2009) alerted us to the possibility that deer
in the current study might develop such reactions. Necropsy
observations and histopathological evaluation revealed that
>85% of the GonaCon-treated and sham-injected deer in
New Jersey had injection-site granulomas or sterile abscesses
in the deep musculature of the hind limbs in October 2007.
The similarity in the incidence of injection-site lesions in
GonaCon-treated and sham-injected adult female deer
strongly suggests that the causative agent(s) was present in
both inocula.
Adjuvants and vaccines often cause localized reactions at
injection sites, including pain, local inflammation, swelling,
necrosis, granulomas, ulcers, and sterile abscesses (Aguilar
and Rodrı´guez 2007). For example, adjuvants that include
alum (Gupta et al. 1995, Valtulini et al. 2005, Reed et al.
2008) or Mycobacterium spp. (Broderson 1989) often cause
reactions at injection sites. Larger amounts of mycobacteria
cause proportionately more inflammation and necrosis
(Broderson 1989). Water-in-oil emulsions, especially those
containing mineral oil, also induce local inflammation and
granuloma formation at injection sites (Humphrey 1982,
Straw et al. 1985, Yamanaka et al. 1992, Macy 1997,
Petrovsky and Aguilar 2004). Injection-site granulomas
and other lesions are routinely encountered in livestock, from
which they are excised at slaughter (George et al. 1995, Van
Donkersgoed et al. 1997, Valtulini et al. 2005). They also
commonly occur in humans (Hay 1995, Bordet et al. 2001,
Marsee et al. 2008).
GonaCon Immunocontraceptive Vaccine contains AdjuVac,
a mineral-oil-based adjuvant developed from a USDA-
approved Johnes disease vaccine called MycoparTM (Fort
Dodge Animal Health). AdjuVac contains killed
Mycobacterium avium, which is needed for GonaCon vaccine
to induce a rapid, strong (Miller et al. 2008a), and sustained
(Perry et al. 2008) contraceptive effect. Mycobacterium spp.
are commonly used in adjuvants to strengthen the immune
response (Gupta et al. 1993, Aguilar and Rodrı´guez 2007).
Like Freund’s complete adjuvant (which contains
Mycobacterium paratuberculosis and has been used extensively
in laboratory animals), AdjuVac’s combination of water-in-
mineral-oil emulsion and killed mycobacteria results in a
highly potent adjuvant that stimulates both humoral and
cellular immunity (Warren et al. 1986). Freund’s complete
adjuvant, however, cannot be used in human or veterinary
vaccines because it may cause severe pain, fever, abscess
formation, and the possibility of permanent organ damage
(Edelman 1980). Leenaars et al. (1998), for example, found
extensive intramuscular lesions in rabbits (Oryctolagus cuni-
culus) and mice (Mus musculus) after injection with FCA and
FIA (as prime and boost, respectively), although palpation
had detected no swelling or nodules. Wild horses injected
with an early formulation of a PZP immunocontraceptive
vaccine that contained FCA developed externally visible
nodules, swelling, and abscesses at injection sites (Roelle
and Ransom 2009). Porcine zona pellucida and GnRH
vaccines (early formulations of GonaCon that contained
FCA or FIA instead of AdjuVac) also caused granulomas
at hand-injection (PZP) and dart-injection (PZP and
GnRH) sites in nearly all treated white-tailed deer in
New York (Curtis et al. 2007, 2008). The intramuscular
injection of large doses of FCA or FIA can cause diffuse
necrosis and extensive atrophy of functional muscle groups,
impairing function (Broderson 1989). Such severe reactions
have not been observed in animals injected with GonaCon
(containing AdjuVac), possibly because of the relatively small
amount of mycobacteria it contains (Miller et al. 2008a), or
because GonaCon uses a different mycobacterial species.
Necrosis of muscle fibers at injection sites was observed in
many of our study deer in New Jersey and in Maryland
(Gionfriddo et al. 2009), and in captive white-tailed deer
(Killian et al. 2006b) and rabbits (Powers et al. 2007) treated
with GonaCon. Exposure to necrotic cells may be necessary
for the maturation of dendritic cells and the initiation of an
immune response (Gallucci et al. 1999, Sauter et al. 2000).
Moreover, the strength of the immune response may be
proportional to the extent of local tissue damage caused
by the inoculum at the injection site (Schijns 2000). Thus
the necrosis of muscle fibers at the injection site by adjuvants
containing alum (Walls 1977), mineral oil (Straw et al. 1985,
Yamanaka et al. 1992), or mycobacteria (Broderson 1989)
may yield important immunological benefits.
Vaccines that contain alum or mycobacteria, or that are
formulated as water-in-oil emulsions, also may induce strong
immune responses because they form a repository (‘‘depot’’)
at the injection site (Glenny et al. 1931, White 1967,
Fukanoki et al. 2000). The vaccine depot slowly releases
antigen, which is carried by maturing, migratory dendritic
cells via afferent lymph vessels to the paracortical regions of
the local draining lymph node, where it is presented to
resting, antigen-specific T cells that are activated by the
now-mature dendritic cells (HogenEsch 2002). Antigen
has been detected in lymph nodes as early as 3 hr after
peripheral injection (Dupuis et al. 1998). Antigen may be
protected and retained for months or even years on follicular
dendritic cells in draining lymph nodes where antibody
formation continues (Greene et al. 1975, Tew and
Mandel 1979, Burton et al. 1994). Subsequent release of
antigen from the depot acts as a secondary stimulus (similar
to a booster injection) to the sensitizing action of the antigen
released previously.
In response to the presence of the vaccine depot, a gran-
uloma develops as the immune system attempts to wall off
the irritating foreign material by enclosing it in a fibrous
capsule of thick connective tissue. Granulomas that develop
156 Wildlife Society Bulletin  35(3)
at injection sites contribute substantially to antibody syn-
thesis because they harbor large numbers of antibody-pro-
ducing plasma cells (White 1967, World Health
Organization 1976). The release rate of antigen from an
injection-site granuloma decreases as the granuloma devel-
ops and becomes encapsulated, and eventually it becomes
insufficient to maintain an optimal antibody response
(Herbert 1968, Lascelles et al. 1989). After the granuloma
is completely walled off and antigen release stops, excision of
the granuloma does not affect antibody formation in the
draining lymph node because antigen is already present there
(Lascelles et al. 1989, Schijns 2000). Active but unused
antigen remains trapped inside the encapsulated granuloma,
as demonstrated by researchers who excised material from
injection-site granulomas and injected it into the same or
different animals, thereby inducing immune responses in the
recipients (Harrison 1935, Holt 1950, Herbert 1968).
Lymph Nodes
Popliteal and iliac lymph nodes are the draining and regional
lymph nodes for the hind limb area where hand injections
were delivered to deer in our study. Enlargement of local
lymph nodes is a normal response to infection or other types
of antigenic stimulation, and also can be caused by injection
of oil emulsions (Yamanaka et al. 1992). Stronger antigens
and adjuvants induce greater inflammation of draining
lymph nodes (Taub et al. 1970).
In our study, popliteal and iliac lymph nodes of noninjected
control male deer were normal, as expected. Many of the
lymph nodes of GonaCon-treated and sham-injected deer,
however, were enlarged, hard, or otherwise reactive, indi-
cating the involvement of these nodes in the drainage of the
intramuscular injection site. These results demonstrate that
the material that caused reactions in lymph nodes was present
in both GonaCon vaccine and in the sham material (which
contained AdjuVac adjuvant and mollusk stabilizing buffer).
The mineral oil (Aucouturier et al. 2001) or the M. avium
(Herbert 1968, Lind 1968) in AdjuVac could have caused the
draining lymph nodes to react. Enlargement of draining
lymph nodes also was reported in captive rabbits (Powers
et al. 2007) and in captive (Killian et al. 2006b) and wild
(Gionfriddo et al. 2009) white-tailed deer treated with
GonaCon vaccine.
In 6 of our study deer, secondary granulomatous inflam-
mation and hyperplasia occurred in draining lymph nodes to
which the irritant at the injection site had been transported
by lymph. Similarly, one of 13 captive adult female white-
tailed deer vaccinated with GonaCon in Pennsylvania devel-
oped granulomatous lymphadenitis in a draining lymph node
(Killian et al. 2006b). Development of granulomas in drain-
ing lymph nodes is common when alum-absorbed adjuvants
(Humphrey 1982), FCA (Yamanaka et al. 1992), or FIA
(Gaafar and Turk 1970) are used. In extreme cases, gran-
ulomatous lesions may replace the majority of the tissue in
lymph nodes (Yamanaka et al. 1992). Unanue and Benacerraf
(1973) demonstrated that granulomatous reactions may be
passively transferred between animals by intravenously
injecting lymph node cells from a granulomatous lymph
node in one animal into a second animal.
The oil droplets detected in the lymph nodes of several of
our study deer probably originated in the inoculum and were
transported via lymphatic vessels to the draining lymph
nodes. Previous studies have documented the presence of
paraffin or mineral oil (used as an adjuvant) in lymph nodes
after subcutaneous or intramuscular injection (White et al.
1955, Freund 1956, Broderson 1989). Long-term (probably
lifelong) retention of oil in body tissues may result from the
use of mineral oil adjuvants (World Health Organization
1976).
MANAGEMENT IMPLICATIONS
GonaCon Immunocontraceptive Vaccine provides a safe and
humane way to reduce reproduction in individual adult
female white-tailed deer, especially in demographically
closed (e.g., fenced or otherwise spatially isolated) popu-
lations. The only adverse reactions to vaccination in our field
study were normal inflammatory responses at injection sites
and in associated draining lymph nodes. These responses
were natural and essential expressions of the strong immune
response that is required to induce temporary infertility.
Safety issues should not impede acceptance of GonaCon
as a deer management tool. Operational use of GonaCon
Immunocontraceptive Vaccine and other wildlife contracep-
tives will likely be limited by efficacy, practicality, and politics
to settings where traditional management methods cannot be
applied. The widespread occurrence of such settings suggests
that the potential contribution of contraceptive agents to
deer management in developed landscapes is substantial. In
addition to its contraceptive effects, GonaCon may improve
deer body condition without the PZP-associated disadvan-
tages of repeated estrous cycling and delayed birth of fawns to
vaccine nonresponders. Although public demand for safe,
humane contraceptive agents like GonaCon will continue to
drive their research and development, wildlife management
agencies and personnel will ultimately determine the value
and applicability of these products.
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